Clinical importance of metabolites of antiarrhythmic drugs
- 1 January 1984
- journal article
- editorial
- Published by Elsevier in The American Journal of Cardiology
- Vol. 53 (1), 248-251
- https://doi.org/10.1016/0002-9149(84)90721-5
Abstract
No abstract availableThis publication has 13 references indexed in Scilit:
- Encainide and its metabolites. Comparative effects in man on ventricular arrhythmia and electrocardiographic intervals.JCI Insight, 1984
- Electrophysiology of oral encainideThe American Journal of Cardiology, 1982
- Metabolite cumulation during long-term oral encainide administrationClinical Pharmacology & Therapeutics, 1982
- Clinical pharmacology and antiarrhythmic efficacy of encainide in patients with chronic ventricular arrhythmias.Circulation, 1981
- Antiarrhythmic efficacy, pharmacokinetics and safety of N-acetylprocainamide in human subjects: Comparison with procainamideThe American Journal of Cardiology, 1980
- Total Suppression of Ventricular Arrhythmias by EncainideNew England Journal of Medicine, 1980
- Electrophysiologic comparative study of procainamide and N-acetylprocainamide in anesthetized dogs: concentration-response relationships.Circulation, 1979
- Cumulation of N‐acetylprocainamide, an active metabolite of procainamide, in patients with impaired renal functionClinical Pharmacology & Therapeutics, 1977
- Acetylation of procainamide in man and its relationship to isonicotinic acid hydrazide acetylation phenotypeClinical Pharmacology & Therapeutics, 1975
- Antiarrhythmic potency of N‐acetylprocainamideClinical Pharmacology & Therapeutics, 1975